|
Schlusskurs
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 10.63 CNY | -1.12% |
|
-0.84% | +5.25% |
| 12.02. | Shyndec Pharmaceutical erhält Zuschläge für 51 Arzneimittel im neuesten chinesischen Beschaffungsprogramm | MT |
| 10.02. | Tochtergesellschaft von Shyndec Pharmaceutical besteht GMP-Inspektion | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.12% | -0.84% | -0.75% | -0.93% | +5.25% | -7.97% | +4.52% | +23.32% | -42.77% | 2.06 Mrd. | |
| -1.02% | +2.64% | -1.82% | +9.33% | +3.22% | -6.57% | -32.18% | -11.57% | +68.58% | 65.94 Mrd. | |
| +3.28% | -2.20% | +10.61% | +13.44% | +18.04% | +36.28% | +61.46% | +59.39% | +953.58% | 9.34 Mrd. | |
| -3.68% | +9.37% | +1.25% | +3.72% | +2.57% | +26.22% | -13.74% | -20.00% | +59.41% | 9.22 Mrd. | |
| -3.70% | +0.65% | -10.05% | -14.89% | -12.36% | -13.06% | +60.82% | -28.39% | - | 5.93 Mrd. | |
| -0.55% | +3.82% | -0.37% | -12.96% | -3.20% | -13.03% | +119.27% | +88.83% | +184.01% | 5.6 Mrd. | |
| +2.43% | +0.64% | +5.15% | +13.41% | -3.62% | +251.78% | +47.11% | +243.23% | +252.86% | 4.32 Mrd. | |
| -2.42% | +4.53% | +59.85% | +103.50% | +61.27% | +417.08% | +955.96% | +178.53% | +1’650.60% | 3.06 Mrd. | |
| +1.99% | -1.57% | +1.15% | +12.98% | +2.29% | +29.99% | +31.85% | +66.31% | +295.95% | 2.92 Mrd. | |
| -2.59% | -2.84% | -10.81% | -15.57% | -1.78% | -10.41% | -27.32% | -67.58% | - | 2.79 Mrd. | |
| -1.38% | -0.32% | -8.55% | -6.51% | -1.58% | +30.78% | +17.70% | +104.78% | - | 2.47 Mrd. | |
| +0.09% | +2.61% | -9.70% | +6.67% | +8.93% | +72.99% | +9.42% | -12.12% | - | 1.88 Mrd. | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64 Mrd. | |
| -0.87% | +6.26% | -11.96% | -3.16% | +13.43% | +53.63% | -21.44% | - | - | 1.59 Mrd. | |
| -0.52% | -5.00% | -24.89% | -3.65% | -6.72% | +37.30% | +4.87% | -1.31% | - | 1.36 Mrd. | |
| -3.08% | -3.63% | +14.42% | -3.82% | +11.50% | +86.67% | +133.87% | +33.51% | +514.63% | 1.34 Mrd. | |
| -7.98% | -12.14% | +9.85% | +41.96% | +0.59% | +316.67% | +32.71% | -64.69% | -92.02% | 1.29 Mrd. | |
| -0.97% | +0.88% | -2.54% | +10.17% | -0.97% | +26.86% | +82.30% | +103.22% | +71.44% | 1.26 Mrd. | |
| -1.35% | -2.16% | -13.41% | +25.98% | +25.21% | +118.78% | +49.37% | +38.91% | - | 1.23 Mrd. | |
| -1.51% | -2.59% | -3.37% | -17.88% | +3.50% | -18.56% | -69.93% | - | - | 1.17 Mrd. | |
| Durchschnitt | -1.25% | +0.02% | +0.21% | +8.51% | +6.61% | +75.55% | +76.14% | +43.20% | +356.02% | 6.32 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.95% | +3.25% | +0.18% | +8.34% | +4.59% | +27.52% | +22.80% | +16.06% | +212.33% |
- Börse
- Aktien
- A0M4PZ Aktie
- Sektor Shanghai Shyndec Pharmaceutical Co., Ltd.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben